IBDEI1EJ ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22673,0)
 ;;=L92.1^^76^975^4
 ;;^UTILITY(U,$J,358.3,22673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22673,1,3,0)
 ;;=3^Necrobiosis Lipoidica NEC
 ;;^UTILITY(U,$J,358.3,22673,1,4,0)
 ;;=4^L92.1
 ;;^UTILITY(U,$J,358.3,22673,2)
 ;;=^5009462
 ;;^UTILITY(U,$J,358.3,22674,0)
 ;;=L20.81^^76^975^8
 ;;^UTILITY(U,$J,358.3,22674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22674,1,3,0)
 ;;=3^Neurodermatitis,Atopic
 ;;^UTILITY(U,$J,358.3,22674,1,4,0)
 ;;=4^L20.81
 ;;^UTILITY(U,$J,358.3,22674,2)
 ;;=^5009108
 ;;^UTILITY(U,$J,358.3,22675,0)
 ;;=D48.5^^76^975^7
 ;;^UTILITY(U,$J,358.3,22675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22675,1,3,0)
 ;;=3^Neoplasm,Skin,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,22675,1,4,0)
 ;;=4^D48.5
 ;;^UTILITY(U,$J,358.3,22675,2)
 ;;=^267777
 ;;^UTILITY(U,$J,358.3,22676,0)
 ;;=D49.2^^76^975^6
 ;;^UTILITY(U,$J,358.3,22676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22676,1,3,0)
 ;;=3^Neoplasm,Bone/Soft Tissue/Skin,Unspec Behavior
 ;;^UTILITY(U,$J,358.3,22676,1,4,0)
 ;;=4^D49.2
 ;;^UTILITY(U,$J,358.3,22676,2)
 ;;=^5002272
 ;;^UTILITY(U,$J,358.3,22677,0)
 ;;=L60.0^^76^975^3
 ;;^UTILITY(U,$J,358.3,22677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22677,1,3,0)
 ;;=3^Nail,Ingrowing
 ;;^UTILITY(U,$J,358.3,22677,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,22677,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,22678,0)
 ;;=L60.9^^76^975^1
 ;;^UTILITY(U,$J,358.3,22678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22678,1,3,0)
 ;;=3^Nail Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,22678,1,4,0)
 ;;=4^L60.9
 ;;^UTILITY(U,$J,358.3,22678,2)
 ;;=^5009240
 ;;^UTILITY(U,$J,358.3,22679,0)
 ;;=Z91.19^^76^975^10
 ;;^UTILITY(U,$J,358.3,22679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22679,1,3,0)
 ;;=3^Noncompliance w/ Medical Treatment/Regimen
 ;;^UTILITY(U,$J,358.3,22679,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,22679,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,22680,0)
 ;;=Z23.^^76^975^5
 ;;^UTILITY(U,$J,358.3,22680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22680,1,3,0)
 ;;=3^Need for Immunization(s)
 ;;^UTILITY(U,$J,358.3,22680,1,4,0)
 ;;=4^Z23.
 ;;^UTILITY(U,$J,358.3,22680,2)
 ;;=^5062795
 ;;^UTILITY(U,$J,358.3,22681,0)
 ;;=E80.1^^76^976^21
 ;;^UTILITY(U,$J,358.3,22681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22681,1,3,0)
 ;;=3^Porphyria Cutanea Tarda
 ;;^UTILITY(U,$J,358.3,22681,1,4,0)
 ;;=4^E80.1
 ;;^UTILITY(U,$J,358.3,22681,2)
 ;;=^5002982
 ;;^UTILITY(U,$J,358.3,22682,0)
 ;;=L56.4^^76^976^20
 ;;^UTILITY(U,$J,358.3,22682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22682,1,3,0)
 ;;=3^Polymorphous Light Eruption
 ;;^UTILITY(U,$J,358.3,22682,1,4,0)
 ;;=4^L56.4
 ;;^UTILITY(U,$J,358.3,22682,2)
 ;;=^5009218
 ;;^UTILITY(U,$J,358.3,22683,0)
 ;;=L10.0^^76^976^4
 ;;^UTILITY(U,$J,358.3,22683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22683,1,3,0)
 ;;=3^Pemphigus Vulgaris
 ;;^UTILITY(U,$J,358.3,22683,1,4,0)
 ;;=4^L10.0
 ;;^UTILITY(U,$J,358.3,22683,2)
 ;;=^91129
 ;;^UTILITY(U,$J,358.3,22684,0)
 ;;=L41.3^^76^976^2
 ;;^UTILITY(U,$J,358.3,22684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22684,1,3,0)
 ;;=3^Parapsoriasis,Small Plague
 ;;^UTILITY(U,$J,358.3,22684,1,4,0)
 ;;=4^L41.3
 ;;^UTILITY(U,$J,358.3,22684,2)
 ;;=^5009173
 ;;^UTILITY(U,$J,358.3,22685,0)
 ;;=L41.4^^76^976^1
 ;;^UTILITY(U,$J,358.3,22685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22685,1,3,0)
 ;;=3^Parapsoriasis,Large Plague
